Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.

被引：0
|
作者：
Fan, Shaoshuang
Jiang, Da
Lv, Yalei
Cui, Yanzhi
Kong, Yan
Dong, Qian
Huang, Fang
Zhang, Xue
Wang, Long
Zhou, Xinliang
Jin, Hui
Li, Ying
Hou, Ran
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15639
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I study of A166 in patients with HER2-expressing locally advanced or metastatic solid tumors.
    Hu, Xichun
    Zhang, Jian
    Liu, Rujiao
    Gao, Shuiping
    Qing, Yan
    Yi, Shuli
    Yuan, Juanjuan
    Chen, Hong
    Fan, Bin
    Zheng, Haochuan
    Wang, Jingyi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
  • [43] The epidemiology of HER-2 positive tumours
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 67 - 67
  • [44] Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer
    Wen, Hai-ni
    Liu, Yi-xi
    Xu, Da
    Zhao, Kai-jing
    Jiao, Zheng
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 159
  • [45] MEGACHEMOTHERAPY WITH HEMATOPOIETIC STEM CELL RESCUE FOR THE TREATMENT OF CHILDREN WITH ADVANCED SOLID TUMORS.
    Cristofani, Lilian M.
    Fernandes, Juliana F.
    Almeida, Maria Tereza A.
    Cornacchioni, Ana Lucia B.
    Azambuja, Alessandra P.
    Gomes, Alessandra
    Franca, Camila P.
    Teixeira, Roberto A. P.
    Maluf, Paulo T.
    Rocha, Vanderson G.
    Odone-Filho, Vicente
    PEDIATRIC TRANSPLANTATION, 2013, 17 (02) : 192 - 192
  • [46] HER-2 positive locally advanced breast cancer: one or two entities?
    Rahal, M.
    Abdelwarith, A.
    Hassen, E.
    Deo, S.
    Ramadan, H.
    Al Naimy, N.
    Al Eissa, N.
    Al Garni, A.
    Al Idrissi, M.
    Al Faraj, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 286 - 286
  • [47] Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
    Kahraman, Seda
    Yalcin, Suayib
    ONCOTARGETS AND THERAPY, 2021, 14 : 4149 - 4162
  • [48] TRASTUZUMAB IN HER-2 POSITIVE ADVANCED GASTRIC CARCINOMA - LONG TERM SURVIVORS
    Natalija, Angelovska Petrusevska
    Nenad, Mitreski
    Biljana, Angelovska
    Violeta, Klisarovska
    Tome, Angelovski
    ANNALS OF ONCOLOGY, 2014, 25 : 52 - 52
  • [49] Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real-world study.
    Feng, Jifeng
    Zhang, Lili
    Wu, Xiaohong
    Zhou, Jun
    Zhu, Mingzhen
    Zhang, Yusong
    Yu, Hao
    Han, Zhengxiang
    Guo, Yujiang
    Guan, Xiaoqing
    Wang, Xufen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Efficacy of Trastuzumab plus Cisplatin Combined with Irinotecan on the Quality of Life of Patients with Advanced Her-2 Positive Gastric Cancer
    Yang, Yu-Xin
    Li, Chun-Ying
    Yin, Wen-Jie
    Chen, Xia
    JOURNAL OF ONCOLOGY, 2022, 2022
12345